This meeting took place in 2018



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Emerging Cellular Therapies: T Cells and Beyond (B6)


Organizer(s) Carl H. June, Marcela V. Maus and Bruce R. Blazar
February 11—15, 2018
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Oct 11, 2017
Abstract Deadline: Nov 9, 2017
Scholarship Deadline: Oct 11, 2017
Discounted Registration Deadline: Dec 13, 2017

Sponsored by BioLegend, Inc., Editas Medicine, Gilead Sciences, Inc., Juno Therapeutics, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc. and Takeda Pharmaceutical Company Limited. This activity was supported by an educational grant from Celgene Corporation.


Summary of Meeting:
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet.

View Meeting Program

Scholarships/Awards

Burroughs Wellcome Fund ECITA Scholarship Recipients

Avery D. Posey
University of Pennsylvania, USA

NCI - 1 R13 CA224778-01 Scholarship Recipients

Angela C. Boroughs
Massachusetts General Hospital/Harvard University, USA

Zinaida Good
Stanford University, USA

Patrick Ho
University of California, Los Angeles, USA

Katelyn Masiuk
University of California, Los Angeles, USA

Margot Pont
Fred Hutchinson Cancer Research Center, USA